Based on the information available, there is no evidence to suggest that Lipitor (atorvastatin), a medication commonly used to treat high cholesterol, can prevent liver disease progression. Lipitor belongs to a class of drugs known as statins, which work by blocking the production of cholesterol in the body. While statins have been shown to have some potential benefits in treating non-alcoholic fatty liver disease (NAFLD) by improving liver enzyme levels and reducing inflammation, there is no evidence to suggest that Lipitor can prevent the progression of liver disease.

It is important to note that the use of Lipitor or any other statin for the treatment of liver disease should be under the close supervision of a healthcare professional. The Food and Drug Administration (FDA) has approved the use of statins for the treatment of high cholesterol and to reduce the risk of heart attack and stroke, but not for the treatment of liver disease.

In summary, while Lipitor and other statins may have some potential benefits in treating certain types of liver disease, there is no evidence to suggest that they can prevent the progression of liver disease. It is essential to consult with a healthcare professional before starting any new medication.

Sources:

1. DrugPatentWatch.com. (n.d.). Atorvastatin. Retrieved from <https://www.drugpatentwatch.com/drugs/atorvastatin>
2. National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Treatment for Nonalcoholic Fatty Liver Disease. Retrieved from <https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/treatment>
3. U.S. Food and Drug Administration. (2019). High Cholesterol Medicines (Statins). Retrieved from <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/high-cholesterol-medicines-statins>